Introduction
NMDL and LCPL are specialized diagnostic laboratories focused on histology, cervix cytology and molecular diagnostics. The companies provide high-quality laboratory services to general practitioners, hospitals and independent treatment centers across the Netherlands. Together they serve a broad national client base of over 2,100 general practitioners.
NMDL and LCPL play a key role in population-based diagnostic screening programs. The platform is one of the accredited laboratories for the Dutch national cervical cancer screening program.
Plain Vanilla invested in NMDL LCPL in 2012 and successfully sold the company in 2018 to Eurofins Scientific.
How Plain Vanilla added value
- Managed founder succession and leadership transition
- Expanded service offering by investing in molecular diagnostic testing capabilities
- Professionalized the organization, systems and operational processes
- Prepared and successfully secured the national cervical cancer screening tender
- Rapidly expanded market share to approximately 30% of Dutch general practitioners